June 7 (Reuters) - Kazia Therapeutics Ltd (KZA) : PHASE II STUDY OF PAXALISIB IN BRAIN METASTASES ADVANCES TO EXPANSION STAGE IN BREAST CANCER BRAIN METASTASES COHORT